Table 3 Characteristics of PAD patients and non-PAD patients
Peripheral arterial disease | P | ||
|---|---|---|---|
+ | – | ||
N | 45 | 140 | |
Age (years) | 72 (64–81) | 69 (59–84) | 0.055 |
Male n (%) | 33 (73.3) | 97 (69.3) | 0.605 |
Smoking n (%) | 17 (37.8) | 58 (41.4) | 0.694 |
Hypertension n (%) | 40 (88.9) | 108 (77.1) | 0.087 |
Dyslipidemia n (%) | 24 (53.3) | 55 (39.3) | 0.056 |
Diabetes mellitus n (%) | 29 (64.4) | 71 (50.7) | 0.108 |
Ischemic heart disease n (%) | 27 (60.0) | 47 (33.6) | 0.001 |
Stroke n (%) | 10 (22.2) | 17 (12.1) | 0.095 |
ARB n (%) | 19 (42.2) | 55 (39.3) | 0.646 |
Statin n (%) | 19 (42.2) | 41 (29.3) | 0.086 |
Hemoglobin (g/dL) | 8.7 (7.3–9.8) | 8.3 (7.0–9.2) | 0.079 |
ABI | 0.92 (0.73–1.08) | 1.22 (1.12–1.29) | < 0.0001 |
SPP | 47 (34–71) | 75 (69–86) | < 0.0001 |
Blood glucose (mg/dL) | 124 (108–181) | 127 (98–160) | 0.406 |
Albumin (g/dL) | 3.2 (2.8–3.6) | 3.3 (2.8–3.6) | 0.637 |
Ca (mg/dL) | 7.8 (7.2–8.4) | 7.7 (7.0–8.3) | 0.486 |
P (mg/dL) | 5.9 (4.7–7.1) | 6.2 (5.0–7.4) | 0.453 |
Total cholesterol (mg/dL) | 176 (153–224) | 158 (135–192) | 0.015 |
Triglyceride (mg/dL) | 98 (71–136) | 101 (76–147) | 0.821 |
HDL-C (mg/dL) | 44.8 (34.6–55.2) | 39.1 (31.0–48.6) | 0.067 |
LDL-C (mg/dL) | 106 (74–124) | 83 (68.3–104.8) | 0.025 |
CRP (mg/dL) | 0.74 (0.615–2.815) | 0.47 (0.120–3.730) | 0.653 |
Cilstazol, n (%) | 6 (13.3%) | 5 (3.5%) | 0.026 |
Sarpogrelate, n (%) | 0 (0%) | 1 (0.7%) | 0.455 |
Aspirin, n (%) | 26 (48.9%) | 22 (22.6%) | 0.0002 |
Prostaglandin analogue, n (%) | 9 (20.5%) | 8 (5.7%) | 0.006 |